| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1416926A4 Zinc containing compositions for anti-viral use |
| 03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
| 03/04/2009 | EP1392312B1 TRIAZOLO 4,5-d PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 03/04/2009 | EP1379269B1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
| 03/04/2009 | CN101378807A Combination of an H3 antagonist/inverse agonist and an appetite suppressant |
| 03/04/2009 | CN101378771A Nutritional system and methods for increasing longevity |
| 03/04/2009 | CN101378761A Cationic steroid antimicrobial compositions and methods of use |
| 03/04/2009 | CN101378760A Pharmaceutical compositions comprising methotrexate |
| 03/04/2009 | CN101378743A Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
| 03/04/2009 | CN101378730A Granular material comprising water-insoluble inorganic phosphate binders |
| 03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
| 03/04/2009 | CN100464785C An anti-cancer drug slow release injection and an application thereof |
| 03/04/2009 | CN100464784C A dietotherapy granule |
| 03/04/2009 | CN100464783C An anti-cancer medicine composition with anti-neoplastic antibiotics |
| 03/04/2009 | CN100464782C A therapeutic agent for fibromyalgia |
| 03/04/2009 | CN100464736C A slow released anticancer injection with both antimetabolite and a synergist thereof |
| 03/04/2009 | CN100464647C A medical agent with amino acids that can increase body temperatures and be used in foods or beverages |
| 03/03/2009 | US7498441 Melanin-concentrating hormone antagonists for eating disorder and diabetes treatment |
| 03/03/2009 | US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression |
| 03/03/2009 | US7498361 Methods of treating tardive dyskinesia and other movement disorders |
| 03/03/2009 | US7498360 Adminisering prostaglandin into ear |
| 03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
| 03/03/2009 | US7498321 17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 03/03/2009 | US7498303 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
| 03/03/2009 | US7498301 Administering or applying anserine for treating muscle spasm, localized swelling, inflammation, joint pains, muscle fatigue, stress and myocardial infarction optionally with a diuretic |
| 03/03/2009 | US7498157 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 03/03/2009 | US7498147 Modulating the activity of one or more elements in the complement/lipid pathway |
| 03/03/2009 | US7498129 Measuring changes in level of antigen recognizable by a monoclonal antibody or antigen binding fragment; monoclonal antibody is produced by hybridoma cell line; decreased level indicates a reduced tumor; diagnosis, cell purification |
| 03/03/2009 | US7498039 Nutritional supplement containing sea water minerals |
| 03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
| 03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
| 03/03/2009 | US7498031 Treating sensorineural hearing loss or a vestibular disorder by administering an a PM-1antibody or an MR16-1 antibody; Meniere's disease, drug-induced inner ear disorders, viral inner ear disorders, purulent inner ear disorders, temporal bone fracture or acoustic nerve tumor |
| 03/03/2009 | US7498020 Medicaments |
| 03/03/2009 | CA2314173C Therapeutic uses of gaseous mixtures of helium and oxygen, in particular in the treatment of asthma |
| 03/03/2009 | CA2270286C Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device |
| 02/26/2009 | WO2009026328A2 Methods of delivery of agents to leukocytes and endothelial cells |
| 02/26/2009 | WO2009026265A1 A method of extending the dose range of vitamin d compounds |
| 02/26/2009 | WO2009026075A1 Methods and compositions for treating cancers |
| 02/26/2009 | WO2009025781A1 Activators of pyruvate kinase m2 and methods of treating disease |
| 02/26/2009 | WO2009025168A1 Sugar-modified liposome containing compound for contrast agent and contrast agent |
| 02/26/2009 | WO2009025159A1 Detection and treatment of schizophrenia |
| 02/26/2009 | WO2009025149A1 Adnf receptor |
| 02/26/2009 | WO2009024763A2 Combination therapy |
| 02/26/2009 | WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 02/26/2009 | WO2009023943A1 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals |
| 02/26/2009 | WO2009008992A3 Combination anti-cancer therapy comprising an inhibitor of both mtorc1 and mt0rc2 |
| 02/26/2009 | WO2009006577A3 Compositions and methods for inhibiting ezh2 |
| 02/26/2009 | WO2008156853A3 Inhibition of filovirus entry into cells and uses thereof |
| 02/26/2009 | WO2008156833A3 G2a receptor as a therapeutic target |
| 02/26/2009 | WO2008152421A3 Modification of cytokine levels with glucosylamine compounds |
| 02/26/2009 | WO2008096122A3 Progesterone for the prevention of preterm birth |
| 02/26/2009 | US20090054720 Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer |
| 02/26/2009 | US20090054527 Administration of capsaicinoids |
| 02/26/2009 | US20090054485 Method of treating neutrophil-related diseases with topical anesthetics |
| 02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
| 02/26/2009 | US20090054385 Solid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | US20090054367 Mycobacterial antigens expressed under low oxygen tension |
| 02/26/2009 | US20090054356 1-substituted-7-(b-d-glycopyranosyloxy)(aza)indole compound and pharmaceutical containing the same |
| 02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
| 02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
| 02/26/2009 | US20090053796 Methods And Compositions For Culturing Spirochetes And Treating Spirochetal Diseases |
| 02/26/2009 | US20090053264 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 02/26/2009 | US20090053234 Methods of Preventing or Treating Inflammatory or Autoimmune Disorders by Administering Integrin ALPHAVBETA3 Antogonists in Combination with other Prophylactic or Therapeutic Agents |
| 02/26/2009 | US20090053216 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of non-hodgkins lymphoma; immunotherapy |
| 02/26/2009 | US20090053163 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/26/2009 | US20090053143 Liquid inhalation formulations of dehydroepiandrosterone derivatives |
| 02/26/2009 | CA2699988A1 Methods and compositions for treating cancers |
| 02/26/2009 | CA2697079A1 A method of extending the dose range of vitamin d compounds |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027871A2 Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/25/2009 | EP2027862A1 Composition for enhancing immune function |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2026823A2 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 02/25/2009 | EP2026796A2 Use of a vasopeptidase inhibitor for the treatment of pulmonary arterial hypertension |
| 02/25/2009 | EP2026790A2 Co-therapy for the treatment of epilepsy and related disorders |
| 02/25/2009 | EP2026786A2 Use of choline-based preparations for the treatment of tinnitus |
| 02/25/2009 | EP2026765A2 Hyperthermic technologies and therapeutic uses thereof |
| 02/25/2009 | EP2026651A2 Combination therapy with non-selective cox inhibitors to prevent cox-related gastric injuries |
| 02/25/2009 | EP1751612B1 Methods and compositions for the treatment of uveitis |
| 02/25/2009 | EP1551451B1 Use of escherichia coli heat labile toxin as an adjuvant in poultry |
| 02/25/2009 | EP1530469B1 Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist |
| 02/25/2009 | EP1392270B1 Abuse resistant pharmaceutical composition containing capsaicin |
| 02/25/2009 | EP1381361B1 Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/25/2009 | EP1254106B1 Calcilytic compounds |
| 02/25/2009 | EP1247532B1 Composition promoting lacrimal secretion |
| 02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
| 02/25/2009 | EP1075277B1 Methods for detecting and inhibiting angiogenesis |
| 02/25/2009 | CN101374553A Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients |
| 02/25/2009 | CN101374552A Medicine for transnasal administration |
| 02/25/2009 | CN101374502A Medicament for topical use |
| 02/25/2009 | CN101374501A Composition and method of use thereof |
| 02/25/2009 | CN101371855A Safety anaesthetic |